Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 265 results for "zydus group"

Zydus Cadila gets USFDA nod for kidney stones tablets
Money Control

Zydus Cadila gets USFDA nod for kidney stones tablets

The group currently has 94 approvals and has so far filed 239 abbreviated new drug applications (ANDA), Cadila Healthcare said. Money Control, 1 month ago
Zydus gets USFDA nod for anti-hypertensive drug Hindu Business Line, 3 weeks ago

Zydus Cadila gets tentative approval from US FDA for Glipizide ER tablets

Zydus Cadila has received tentative approval from the US FDA (Food and Drug Administration) to market Glipizide Extended-release (ER) tablets in the strengths of 2.5 mg, 5 mg, and 10 mg. The drug falls in the ant-diabetic segment. The estimated ...
 Indian-Commodity3 days ago Zydus gets USFDA tentative nod for diabetic tablets  Press Trust of India3 days ago Zydus receives tentative approval for Glipizide ER tablets  India Infoline3 days ago Zydus gets tentative nod for Glipizide ER tablets  MyIris3 days ago

Zydus and Gilead Enter into a Generic Licensing Agreement to manufacture breakthrough treatment for Hepatitis C

Zydus and Gilead Sciences, Inc. have signed a non-exclusive licensing agreement which will allow the generic manufacture of sofosbuvir and the investigational single tablet regimen of ledipasvir/sofosbuvir for distribution in 90 developing ...
 Equity Bulls2 days ago Zydus granted license to produce generic hepatitis C drug  Smart Investor3 days ago Zydus gets Gilead licence for Hepatitis C treatment  Hindu Business Line3 days ago
Business Standard India

Zydus Cadila bags license for hepatitis C drug

medabad-based pharma major Cadila Healthcare (Zydus Cadila) today announced that it has signed a non-exclusive licensing agreement with Gilead Sciences Inc, which will allow the generic manufacture of sofosbuvir and ledipasvir (used for treatment of ...
 Business Standard India3 days ago

Pharmaceutical Market India 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMs), Biosimilars, Generics & Vaccines

FEATURED COMPANIES Aurobindo Pharma Cipla Dr Reddy's Laboratories Mankind Pharma Piramal Group Reliance Life Sciences MORE PHARMACEUTICAL MARKET INDIA 2014-2020, ...
 Research and Markets2 months ago Renal Anemia - Pipeline Review, H2 2014 - 22 Companies & 25 Drug Profiles  Individual.com1 week ago Research and Markets: Renal Anemia - Pipeline Review, H2 2014 - 22 Companies & 25 Drug Profiles  TMC Net1 week ago Needle-Free Delivery: Technology and Market Forecast 2014-2024  Financial Content3 weeks ago
Manila Standard Today

It's more than just beauty and being sexy

THE Marie France Group of Companies held its 3rd medical mission in Barangay Sagad, Pasig last weekend. Dubbed Marie France Gives Back, the activity served over 1,000 residents through free medical consultations, comprehensive check-ups and ...
 Manila Standard Today2 months ago

Emvies 2014: Maxus is Media Agency of the Year; HUL wins Client of the Year

BEST MEDIA STRATEGY CONSUMER PRODUCTS NO. AGENCY NAME BRAND NAME CAPTION TITLE CLIENT NAME G / S / B 1 Maxus Tata Tea Gold PO49 Elections: The Media Movement that Changed the Role of Women in Indian Elections Tata Global Beverages ...
 Best Media Info1 day ago

Gujarat captains of industry in full attendance to meet Xi Jinping

Captains of Gujarat Industry attended the meeting between prime minister Narendra Modi and Chinese president Xi Jinping at Hyatt in Ahmedabad on Wednesday evening. Nearly 50 people from leading companies and industries associations were invited at ...
 DNA India1 day ago

Sensex falls 244 pts, Nifty ends below 8050; pharma steady

03:30 Market closing: After a tough struggle, the market ended on a lower note. The Sensex was down 244.48 points or 0.9 percent at 26816.56 and the Nifty slipped 63.50 points or 0.8 percent at 8042.00. About 1750 shares advanced, 1310 shares ...
 Moneycontrol.com3 days ago

Form IV contained in Schedule II to the Combination Regulations under Sec 29(2) of Competition Act, 2002 (as amended)

I. The Competition Commission of India ("Commission") is investigating the combination between Sun Pharmaceutical Industries Limited ("Sun") having its registered office at SPARC, Tandalja, Vadodra - 390 020, Gujarat, India and Ranbaxy Laboratories ...
 Noodls2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less